Exagen (XGN) Share-based Compensation (2018 - 2026)
Exagen filings provide 9 years of Share-based Compensation readings, the most recent being $655000.0 for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 57.07% to $655000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $2.4 million, a 47.26% increase, with the full-year FY2025 number at $2.2 million, up 22.4% from a year prior.
- Share-based Compensation hit $655000.0 in Q1 2026 for Exagen, down from $705000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.4 million in Q2 2022 to a low of $217000.0 in Q3 2024.
- Median Share-based Compensation over the past 5 years was $655000.0 (2026), compared with a mean of $758647.1.
- Biggest five-year swings in Share-based Compensation: plummeted 75.62% in 2024 and later surged 173.27% in 2025.
- Exagen's Share-based Compensation stood at $582000.0 in 2022, then surged by 31.1% to $763000.0 in 2023, then crashed by 43.25% to $433000.0 in 2024, then soared by 62.82% to $705000.0 in 2025, then dropped by 7.09% to $655000.0 in 2026.
- The last three reported values for Share-based Compensation were $655000.0 (Q1 2026), $705000.0 (Q4 2025), and $593000.0 (Q3 2025) per Business Quant data.